This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Huntsman (HUN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Huntsman (HUN) closed at $23.23 in the latest trading session, marking a +1.75% move from the prior day.
Huntsman (HUN) Q3 Earnings Match, Revenues Top Estimates
by Zacks Equity Research
Huntsman (HUN) is committed to balanced approach to capital allocation by growing its downstream businesses portfolio.
Huntsman (HUN) Meets Q3 Earnings Estimates
by Zacks Equity Research
Huntsman (HUN) delivered earnings and revenue surprises of 0.00% and 9.15%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Huntsman (HUN) in Q3 Earnings?
by Anindya Barman
While Huntsman (HUN) faces headwind from higher raw material costs, it should gain from growth in downstream specialty and formulation businesses in Q3.
Zacks.com featured highlights include: MGM, Huntsman, Principal Financial, Unum and Wintrust
by Zacks Equity Research
Zacks.com featured highlights include: MGM, Huntsman, Principal Financial, Unum and Wintrust
Huntsman (HUN) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
Huntsman (HUN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pick These 5 Bargain Stocks With Alluring EV/EBITDA Ratios
by Anindya Barman
We have screened bargain stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.
Are You Looking for a High-Growth Dividend Stock? Huntsman (HUN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Huntsman (HUN) have what it takes? Let's find out.
Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman
by Zacks Equity Research
Zacks.com highlights: Manulife Financial, Jazz Pharmaceuticals, DaVita, American Axle & Manufacturing Holdings and Huntsman
Should Value Investors Buy Huntsman (HUN) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Low Price-to-Book Stocks to Buy in a Volatile Market
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
HUN vs. APD: Which Stock Is the Better Value Option?
by Zacks Equity Research
HUN vs. APD: Which Stock Is the Better Value Option?
Are You Looking for a High-Growth Dividend Stock? Huntsman (HUN) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Huntsman (HUN) have what it takes? Let's find out.
Zacks.com featured highlights include: MetLife, Stifel Financial, Rayonier Advanced, ON Semiconductor and Huntsman
by Zacks Equity Research
Zacks.com featured highlights include: MetLife, Stifel Financial, Rayonier Advanced, ON Semiconductor and Huntsman
Can Huntsman (HUN) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Huntsman (HUN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cabot (CBT) Set to Raise Global Prices of Activated Carbon
by Zacks Equity Research
Cabot (CBT) decides to raise activated carbon prices in response to escalating raw material costs and currency fluctuations.
Westlake Chemical to Acquire NAKAN, Expand Global Footprint
by Zacks Equity Research
Westlake Chemical's (WLK) latest deal enables the company to expand its compounding business globally.
Is Huntsman (HUN) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Barrick & Shandong Gold Enter Into Cross Shareholding Deal
by Zacks Equity Research
Barrick's (ABX) move to ink cross shareholding deal strengthens its partnership with Shandong Gold.
5 Reasons That Make ArcelorMittal (MT) Stock a Solid Pick Now
by Anindya Barman
Strong fundamentals and upbeat prospects make ArcelorMittal (MT) an attractive investment choice.
Boost Your Portfolio With These 5 Low P/B Ratio Stocks
by Zacks Equity Research
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects.
Why Should You Add Steel Dynamics (STLD) to Your Portfolio?
by Anindya Barman
Based on its compelling prospects, we believe Steel Dynamics (STLD) has plenty of upside potential.
Eastman Chemical Raises Prices of Methanol Methyl Acetate
by Zacks Equity Research
Eastman Chemical (EMN) plans to lift list and off-list prices of Methyl Acetate in North America starting Oct 1.
Barrick, Randgold in $18.3B Merger, To Form Gold-Mining Giant
by Nilanjan Gupta
Barrick Gold's (ABX) latest deal with Randgold to create an industry-leading gold company with the highest concentration of Tier One Gold Assets.
5 Reasons That Make Cleveland-Cliffs (CLF) a Solid Pick Now
by Zacks Equity Research
Upbeat prospects along with strong fundamentals make Cleveland-Cliffs (CLF) an attractive investment choice.